Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease
4-乙酰氨基-2-(3,5-二甲基吡唑-1-基)-6-吡啶基嘧啶作为 A2A 腺苷受体拮抗剂治疗帕金森病的先导化合物优化
期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/jm800851u
Xiaohu Zhang, John E Tellew, Zhiyong Luo, Manisha Moorjani, Emily Lin, Marion C Lanier, Yongsheng Chen, John P Williams, John Saunders, Sandra M Lechner, Stacy Markison, Tanya Joswig, Robert Petroski, Jaime Piercey, William Kargo, Siobhan Malany, Mark Santos, Raymond S Gross, Jenny Wen, Kayvon Jalal